| Medicare NCD | NCD 110.4 - Extracorporeal Photopheresis | 2024-10-01 |
| Medicare NCD | NCD 260.9 - Heart Transplants | 2024-10-01 |
| Medicare NCD | NCD 200.3 - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) | 2024-10-01 |
| Ambetter Health Iowa Clinical | Concert Genetic Testing: Pharmacogenetics (Version B) | 2024-10-01 |
| Ambetter Health Alabama Clinical | Concert Genetic Testing: Pharmacogenetics (Version B) (V1.2025) | 2024-10-01 |
| Ambetter Health Georgia Clinical | Concert Genetic Testing: Pharmacogenetics (Version B) | 2024-10-01 |
| Ambetter Health Kentucky WellCare Clinical | Concert Genetic Testing: Pharmacogenetics (Version B) (V1.2025) | 2024-10-01 |
| Ambetter Health Nebraska Clinical | Electric Tumor Treating Fields | 2024-10-01 |
| Ambetter Health Nebraska Clinical | Stereotactic Body Radiation Therapy | 2024-10-01 |
| Wellcare Florida Medicare Clinical | STEREOTACTIC RADIATION THERAPY: STEREOTACTIC RADIOSURGERY (SRS) | 2024-10-01 |